Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD) (Q73155409)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 March 1997

Language	Label	Description	Also known as
English	Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)	scientific article published on 01 March 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

based on heuristic

inferred from title

author name string

C Tournigand

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Louvet

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A de Gramont

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

E Lucchi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J F Seitz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F Mal

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

E Raymond

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J Cady

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

E Carola

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Krulik

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

0 references

publication date

1 March 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

79

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1094-1099

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Preclinical and clinical aspects of biomodulation of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1094%3A%3AAID-CNCR6%3E3.0.CO%3B2-G

21 January 2018

Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1094%3A%3AAID-CNCR6%3E3.0.CO%3B2-G

21 January 2018

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1094%3A%3AAID-CNCR6%3E3.0.CO%3B2-G

21 January 2018

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1094%3A%3AAID-CNCR6%3E3.0.CO%3B2-G

21 January 2018

A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1094%3A%3AAID-CNCR6%3E3.0.CO%3B2-G

21 January 2018

Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1094%3A%3AAID-CNCR6%3E3.0.CO%3B2-G

21 January 2018

High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1094%3A%3AAID-CNCR6%3E3.0.CO%3B2-G

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1094%3A%3AAID-CNCR6%3E3.0.CO%3B2-G

21 January 2018

Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1094%3A%3AAID-CNCR6%3E3.0.CO%3B2-G

21 January 2018

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970315%2979%3A6%3C1094%3A%3AAID-CNCR6%3E3.0.CO%3B2-G

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19970315)79:6<1094::AID-CNCR6>3.0.CO;2-G

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9070485%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73155409&oldid=2230217645"